Skip to content

Observation on the therapeutic effect of acupuncture and bloodletting at Shaoshang and Shangyang acupoints on acute sore throat after laryngeal mask anesthesia for breast surgery

Observation on the therapeutic effect of acupuncture and bloodletting at Shaoshang and Shangyang acupoints on acute sore throat after laryngeal mask anesthesia for breast surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000175
Enrollment
Unknown
Registered
2025-01-25
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute sore throat after general anesthesia with laryngeal mask for breast surgery

Interventions

control group:Intravenous infusion of Flurbiprofen Axetil Injection 50mg,Massage the patients hands and instruct them to swallow saliva
Treatment group:Intravenous infusion of Flurbiprofen Axetil Injection 50mg,combined with acupuncture and bloodletting at both Shaoshang and Shangyang acupoints

Sponsors

The First Affiliated Hospital of Henan University of CM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) The anesthesia method is laryngeal mask anesthesia; (2) Patients who meet the diagnosis of postoperative sore throat (patients who have fully recovered consciousness and express sore throat 30 minutes after removing the laryngeal mask) (3) Female, aged between 18 and 60 years old; (4) ASA classification is I-II level; (5)BMI 15~ 25kg /m2 (6) Voluntarily participate in this study and sign the informed consent form; (7) Not involved in other clinical studies.

Exclusion criteria

Exclusion criteria: (1) Pregnant women; (2) Breast cancer surgery patients; (3) Individuals with upper respiratory tract infections within 2 weeks; (4) Those who are currently experiencing acute pharyngitis or acute onset of chronic pharyngitis; (5) Difficult airway conditions such as restricted head and neck movement or mouth opening; (6) Patients with a history of gastroesophageal reflux disease; (7) Individuals with mental illness or communication disorders; (8) Patients who are currently taking anticoagulant drugs or have coagulation dysfunction; (9)Patients who have taken psychotropic or opioid drugs intermittently within the past 3 months or within 1 month (10)Patients who have participated in other clinical trials within the past four weeks (11)The researchers believe that patients who are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
The degree of sore throat;

Secondary

MeasureTime frame
BP HR;CRP;Complications in the pharynx;WBC;

Countries

China

Contacts

Public Contactzhujianpo

The First Affiliated Hospital of Henan University of CM

jianbo9527@sina.com13613841466

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026